Weight loss drug gets Long-Term safety check
NCT ID NCT06671821
Summary
This study followed 81 people with obesity to check the long-term safety and continued weight loss effects of an experimental drug called HRS-7535. It was an extension of a previous trial, so all participants had already taken the drug for 36 weeks. Researchers tracked side effects and measured changes in weight and waist size over an additional 32 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC WEIGHT MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100039, China
Conditions
Explore the condition pages connected to this study.